Friday , November 24 2017
Home / Resources / Exclusive Interviews (page 46)

Exclusive Interviews

Exclusive interviews with researchers from all across the globe containing information that is or was breaking news.

Dr. Richard Bergman, Part 2 – Insulin Resistance Risk Factors

Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association's 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.

Read More »

Dr. Richard Bergman, Part 1 – Measuring Insulin Resistance

Diabetes in Control Publisher Steve Freed meets with Dr. Richard Bergman at the 75th ADA Scientific Sessions in Boston. In this first installment, Dr. Bergman shares his start in diabetes research and explains the high points of his presentation, Comparative Methods for Assessment of Insulin Sensitivity: Oral Vs. Intravenous. Dr. Richard Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

Read More »

Dr. Larry Hirsch, Part 4: Infusion Set Comparison

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.

Read More »

Dr. Larry Hirsch, Part 3: Silent Occlusion

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. This week, Dr. Hirsch discusses the unexplainable highs, known as silent occlusions, that some patients using pumps may experience.

Read More »

Dr. Larry Hirsch, Part 2: BD Investigation Into Infusion Sets

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice PresidLarry Hirschent of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. This week, Dr. Hirsch shares the results of his investigation into infusion sets, the "achilles heel of pumps," which have rarely been the focus of past research. BD is working toward an innovative change to this common technology.

Read More »

Dr. Paresh Dandona, Part 2: Advancements in Diabetes Care

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, continues his discussion with Associate Medical Editor Joy Pape at the 2015 ADA Sessions in Boston. This week, he shares his thoughts on the greatest advancements in diabetes care.

Read More »

Dr. Paresh Dandona, Part 1: GLP-1 Receptor Agonists as Adjunctive Treatment in Type 1 Diabetes

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, joins Associate Medical Editor Joy Pape in a discussion at the 2015 ADA Sessions in Boston regarding highlights of his presentation, "GLP-1 Receptor Agonists as Adjunctive Treatment in Type 1 Diabetes."

Read More »